ACell, Inc. Enters into Exclusive Long-Term Product Supply and Distribution Agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd
April 08, 2019 at 11:55 am
Share
ACell, Inc. announced that it has entered into an exclusive long-term product supply and distribution agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd. The terms of the distribution agreement grant exclusive rights to Weihai Jierui for the sale, marketing, and distribution of ACell's MicroMatrix® and Cytal® Wound Matrix devices in China and Hong Kong for 10 years after marketing clearance. Weihai Jierui has also committed to collaborate with ACell on obtaining regulatory approvals necessary prior to commercialization.
ACell Inc is a United States-based company that provides wound management solutions. The Company offers a range of products, including Cytal Burn Matrix, which is a medical device used for the management of second degree burns; Cytal Wound Matrix, which is are used for acute wounds and chronic wounds; Gentrix Surgical Matrix, which is used in a range of surgical procedures, including various types of hernia repair, and MicroMatrix, which is used for acute wounds and chronic wounds. The Company uses MatriStem UBM (Urinary Bladder Matrix) technology for the manufacturing of Gentrix, Cytal, and MicroMatrix product lines.
ACell, Inc. Enters into Exclusive Long-Term Product Supply and Distribution Agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd